Islet amyloid polypeptide tonally inhibits β-, α-, and δ-cell secretion in isolated rat pancreatic islets

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 1 39-1, 1999, Pages

  Wang, Feng ^a,d   Adrian, Thomas E ^c   Westermark, Gunilla T ^b   Ding, Xianzhong ^c   Gasslander, Thomas ^b   Permert, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amylin; Glucagon; Insulin; Somatostatin

Indexed keywords

AMYLIN; AMYLOID PROTEIN; CALCITONIN GENE RELATED PEPTIDE; GLUCAGON; INSULIN; POLYPEPTIDE; SOMATOSTATIN;

ANIMAL CELL; ARTICLE; CELL ISOLATION; COMPETITIVE INHIBITION; DRUG RECEPTOR BINDING; GLUCAGON RELEASE; HORMONE RELEASE; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0032946303     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.1.e19     Document Type: Article

References (29)

1. Adrian, T. E., A. J. Barnes, R. G. Long, D. J. O'Shaughnessy, M. R. Brown, J. Rivier, W. Vale, A. M. Blackburn, and S. R. Bloom. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J. Clin. Endocrinol. Metab. 53: 675-681, 1981.
2. Ar'Rajab, A., and B. Ahrén. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. Eur. J. Pharmacol. 192: 443-446, 1991.
3. Barakat, A., G. Skoglund, C. Boissard, G. Rosselin, and J. C. Marie. Calcitonin gene-related peptide and islet amyloid polypeptide stimulate insulin secretion in RINm5F cells through a common receptor coupled to a generation of cAMP. Biosci. Rep. 14: 1-13, 1994.
4. Bennet, W. M., C. S. Beis, M. A. Ghatei, P. G. H. Byfield, and S. R. Bloom. Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia 37: 436-438, 1994.
5. Bretherton-Watt, D., S. G. Gilbey, M. A. Ghatei, J. Beacham, and S. R. Bloom. Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia 33: 115-117, 1990.
6. Broderick, C. L., G. S. Brooke, R. D. DiMarchi, and G. Gold. Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 177: 932-938, 1991.
7. Butler, P. C., J. Chou, W. B. Carter, Y. N. Wang, B. H. Bu, D. Chang, J. K. Chang, and R. A. Rizza. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
8. Cooper, G. J. S., A. C. Willis, A. Clark, R. C. Turner, R. B. Sim, and K. B. M. Reid. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632, 1987.
9. Dégano, P., R. A. Silvestre, M. Salas, E. Peiró, and J. Marco. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul. Pept. 43: 91-96, 1993.
10. Fehmann, H. C., V. Weber, R. Göke, B. Göke, R. Eissele, and R. Arnold. Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem. Biophys. Res. Commun. 167: 1102-1108, 1990.
11. Fürnsinn, C., H. Leuvenink, M. Roden, P. Nowotny, B. Schneider, M. Rohac, T. Pieber, M. Clodi, and W. Waldhäusl. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E300-E305, 1994.
12. Inoue, K., S. Hiramatsu, A. Hisatomi, F. Umeda, and H. Nawata. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas. Horm. Metab. Res. 25: 135-137, 1993.
13. Itoh, M., L. Mandarino, and J. E. Gerich. Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro. Diabetes 29: 693-696, 1980.
14. Ohsawa, H., A. Kanatsuka, T. Yamaguchi, H. Makino, and S. Yoshida. Islet amyloid polypeptide inhibits glucose-stimu-lated insulin secretion from isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 160: 961-967, 1989.
15. Panagiotidis, G., A. A. Salehi, P. Westermark, and I. Lundquist. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin, and glucose in the mouse. Diabetes Res. Clin. Pract. 18: 167-171, 1992.
16. Peiró, E., P. Dégano, R. A. Silvestre, and J. Marco. Inhibition of insulin release by amylin is not mediated by changes in somatostatin output. Life Sci. 49: 761-765, 1991.
17. Pettersson, M., and B. Ahrén. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats. Acta Physiol. Scand. 138: 389-394, 1990.
18. Pieber, T. R., J. Roitelman, Y. Lee, K. L. Luskey, and D. T. Stein. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E156-E164, 1994.
19. Poyner, D. Pharmacology of receptors for calcitonin gene-related peptide and araylin. Trends Pharmacol. Sci. 16: 424-428, 1995.
20. Samols, E., J. I. Stagner, R. B. L. Ewart, and V. Marks. The order of islet microvascular cellular perfusion is B→A-→D in the perfused rat pancreas. J. Clin. Invest. 82: 350-353, 1988.
21. Schatz, H., and U. Kullek. Studies on the local (paracrine) actions of glucagon, somatostatin and insulin in isolated islets of rat pancreas. FEBS Lett. 122: 207-210, 1980.
22. Silvestre, R. A., M. Salas, J. Rodríguez-Gallardo, O. García-Hermida, T. Fontela, and J. Marco. Effect of (8-32) salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: study in the perfused pancreas of the rat. Br. J. Pharmacol. 117: 347-350, 1996.
23. Vonen, B., J. Florholmen, D. Malm, P. Torjessen, and P. G. Burhol. Glucagon mediates arginine-induced somatostatin secretion from isolated rat pancreatic islets. Scand. J. Clin. Lab. Invest. 52: 107-112, 1992.
24. Wagoner, P. K., C. Chen, J. F. Worley, I. D. Dukes, and G. S. Oxford. Amylin modulates β-cell glucose sensing via effects on stimulus-secretion coupling. Proc. Natl. Acad. Sci. USA 90: 9145-9149, 1993.
25. Wang, F., G. Westermark, T. Gasslander, and J. Permert. Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets. Regul. Pept. 72: 61-67, 1997.
26. Wang, Z. L., W. M. Bennet, M. A. Ghatei, P. G. H. Byfleld, D. M. Smith, and S. R. Bloom. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42: 330-335, 1993.
27. Westermark, G., M. Benig-Arora, N. Fox, R. Carroll, S. J. Chan, P. Westermark, and D. F. Steiner. Amyloid formation in response to β cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol. Med. 1: 542-553, 1995.
28. Westermark, P., C. Wernstedt, E. Wilander, D. W. Hayden, T. D. O'Brien, and K. H. Johnson. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. USA 84: 3881-3885, 1987.
29. 8-37hC-GRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol. Cell. Endocrinol. 84: R1-R5, 1992.